AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (5)

• AbbVie Approaching $11 Billion Deal for Apogee Therapeutics, Report Says Bloomberg.com · 1d ago
• AbbVie would gain an experimental eczema drug by buying biotech: report MarketWatch · 1d ago
• AbbVie said to be nearing a $10.9B deal to buy Apogee Therapeutics Seeking Alpha · 1d ago
• AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics Financial Times · 1d ago
• AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports Reuters · 1d ago

Related trends